iRadimed: Q4 Earnings Insights

Comments
Loading...

 

iRadimed IRMD reported its Q4 earnings results on Friday, February 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

iRadimed beat estimated earnings by 57.14%, reporting an EPS of $0.33 versus an estimate of $0.21, which surprised analysts.

Also check this: Executives Buy More Than $28M Of 4 Stocks

Revenue was up $3.33 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.06, which was followed by a 3.09% increase in the share price the next day.

Here's a look at iRadimed's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 0.17 0.09 0.10 0.10
EPS Actual 0.23 0.14 0.13 0.07
Revenue Estimate 10.40M 8.46M 8.56M 8.44M
Revenue Actual 10.91M 9.81M 9.22M 8.55M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

IRMD Logo
IRMDiRadimed Corp
$52.33-0.32%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum80.72
Growth74.54
Quality87.92
Value40.36
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: